Can I receive the quadrivalent HPV vaccine if infected with HPV type 58?

Generally, individuals infected with HPV type 58 can usually receive the quadrivalent HPV vaccine. However, if they are outside the recommended age range, vaccination is typically not advised. The specific situation varies from person to person, and a detailed analysis is as follows:

Infection with HPV type 58 is considered a high-risk HPV infection. Nevertheless, receiving the quadrivalent HPV vaccine is still possible, as this vaccine primarily prevents infections caused by HPV types 6, 11, 16, and 18. Since an existing HPV 58 infection does not conflict with the quadrivalent vaccine, vaccination remains an option. However, regular follow-up examinations are still necessary to prevent the development of cervical cancer. After being infected with HPV 58, increasing outdoor physical activity to boost immunity is recommended. In most cases, the virus may clear within about one year, turning negative. It is advisable to have regular hospital check-ups to monitor whether the HPV virus has become negative.

The quadrivalent HPV vaccine is approved for individuals aged 9 to 45 years. Vaccination is generally not recommended for those outside this age range. Therefore, before receiving the quadrivalent HPV vaccine, individuals should confirm whether they meet the eligibility criteria. Prior to vaccination, it is recommended to undergo TCT (thinprep cytologic test) and colposcopy to determine whether precancerous cervical epithelial lesions are present. Only after confirming no such abnormalities can the full vaccination series be completed.

After vaccination, avoid getting the injection site wet to prevent infection and ensure proper wound healing.